Compared to Estimates, Nutrien (NTR) Q2 Earnings: A Look at Key Metrics

Nutrien (NTR) reported Q2 2025 EPS of $2.65, significantly beating the $2.40 consensus estimate by 10.42%, despite revenue of $10.44 billion missing expectations by 1.62%. The earnings outperformance was underpinned by strong operational metrics, including Potash and Nitrogen sales volumes and Phosphate average selling prices exceeding analyst estimates, alongside robust year-over-year sales growth of 29.8% in Potash and 19% in Nitrogen. Despite these positive operational results, NTR shares have declined 3.7% over the past month, underperforming the S&P 500.

Analysis

Nutrien's Q2 2025 results present a mixed but fundamentally strong picture, characterized by a significant earnings beat that was overshadowed by a slight revenue miss. The company reported EPS of $2.65, surpassing the consensus estimate of $2.40 by a notable 10.42%, while total revenue of $10.44 billion fell short of the $10.61 billion estimate by 1.62%. The earnings outperformance was driven by robust operational execution in its core wholesale segments. Specifically, Potash sales grew an impressive 29.8% year-over-year to $1.09 billion, and Nitrogen sales increased 19% to $1.41 billion, with both segments exceeding analyst estimates for sales volumes. Furthermore, the Phosphate segment demonstrated significant pricing power, with the average selling price per tonne of $714 beating the $650.70 estimate. This strength in the commodity-driven businesses, however, was partially offset by weakness in the Sales-Retail (Nutrient Ag Solutions) division, which saw revenue decline 1.4% year-over-year to $7.96 billion, missing the $8.4 billion consensus. Despite the positive underlying fundamentals and profit beat, the stock has underperformed, returning -3.7% over the past month against the S&P 500's +0.5% gain, suggesting the market may be weighing the retail weakness and headline revenue miss more heavily.

Key Decisions for Investors

• Investors should look past the headline revenue miss and focus on the fundamental strength in the Potash and Nitrogen segments, where both sales volumes and revenues significantly outpaced analyst expectations and showed strong year-over-year growth.
• Monitor the performance of the Retail (Nutrient Ag Solutions) segment, as its 1.4% year-over-year sales decline and miss on estimates represents the primary source of weakness in an otherwise strong operational report.
• Consider the stock's recent -3.7% underperformance as a potential valuation opportunity, given the robust 10.42% EPS beat and demonstrated pricing power in key commodity segments.
• Acknowledge the current Zacks Rank #3 (Hold) as an indicator of expected in-line market performance, reflecting the balance between strong wholesale fundamentals and softness in the retail division.